A detailed history of Pendal Group LTD transactions in Perkinelmer Inc stock. As of the latest transaction made, Pendal Group LTD holds 581,900 shares of PKI stock, worth $70.4 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
581,900
Previous 576,157 1.0%
Holding current value
$70.4 Million
Previous $69.3 Million 17.65%
% of portfolio
0.67%
Previous 0.67%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

BUY
$119.0 - $147.98 $683,417 - $849,849
5,743 Added 1.0%
581,900 $0
Q3 2022

Oct 18, 2022

BUY
$118.07 - $160.96 $68 Million - $92.7 Million
576,157 New
576,157 $69.3 Million
Q1 2021

May 03, 2021

SELL
$120.35 - $160.53 $445,535 - $594,282
-3,702 Closed
0 $0
Q4 2020

Jan 21, 2021

BUY
$122.05 - $147.91 $451,829 - $547,562
3,702 New
3,702 $531,000
Q2 2020

Aug 07, 2020

SELL
$70.83 - $105.31 $419,455 - $623,645
-5,922 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$79.1 - $97.45 $3,796 - $4,677
-48 Reduced 0.8%
5,922 $575,000
Q3 2019

Nov 12, 2019

SELL
$79.44 - $98.79 $11,280 - $14,028
-142 Reduced 2.32%
5,970 $508,000
Q2 2019

Aug 01, 2019

SELL
$84.06 - $101.12 $52,369 - $62,997
-623 Reduced 9.25%
6,112 $0
Q1 2019

May 01, 2019

SELL
$72.79 - $97.5 $8,225 - $11,017
-113 Reduced 1.65%
6,735 $0
Q4 2018

Jan 30, 2019

BUY
$71.87 - $97.02 $1,437 - $1,940
20 Added 0.29%
6,848 $537,000
Q3 2018

Nov 05, 2018

SELL
$72.59 - $97.27 $76,509 - $102,522
-1,054 Reduced 13.37%
6,828 $0
Q2 2018

Jul 18, 2018

SELL
$72.1 - $79.39 $13,410 - $14,766
-186 Reduced 2.31%
7,882 $0
Q1 2018

May 08, 2018

BUY
$72.06 - $82.75 $26,373 - $30,286
366 Added 4.75%
8,068 $0
Q3 2017

Nov 01, 2017

SELL
$62.95 - $69.48 $10,323 - $11,394
-164 Reduced 2.08%
7,702 $0
Q2 2017

Aug 11, 2017

BUY
N/A
7,866
7,866 $0

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.